Mushrooms for the Mind & Immune System | Paul Stamets

Andrew Huberman Andrew Huberman • Nov 16, 2026

Audio Brief

Show transcript
Applied mycologist Paul Stamets warns that H5N1 bird flu has jumped to 90 mammal species and carries a 40 to 50 percent human fatality rate, asking whether old-growth forest fungi could help us fight back. On this episode of the Huberman Lab podcast, released on November 16, 2026, host Andrew Huberman speaks with Stamets about the science of fungi. By the end, you will understand how mushroom networks bolster human immunity, enhance vaccine efficacy, drive brain plasticity, and support ecological health. The real immune power of a mushroom hides underground. While the mushroom fruitbody we see above ground rots quickly and has a poor immune system, Stamets explains that underground mycelium is the true fungal immune system, expressing 10 to 100 times more genes. When Huberman asks if eating mushrooms drove fetal brain growth in evolving primates, Stamets hedges that he does not know and wants to be careful what he says. That underground defense system explains why whole fungal extracts outlast and outperform isolated chemicals. An extract of the old-growth forest fungus Agarikon sat in a Mason jar for 17 years at room temperature plus four years refrigerated, yet still healed cells damaged by COVID-19 in lab dishes within five days. Stamets also cites studies showing that growing mycelium on rice ferments the grain, stimulating anti-inflammatory immune proteins that prevent deadly immune overreactions. Lab dishes are one thing, but human and agricultural trials show how fast these fermented extracts work in the real world. In a privately funded trial of 90 people getting mRNA COVID vaccines alongside Agarikon and Turkey Tail mycelium grown on rice, participants had significantly fewer vaccine side effects and triple the COVID antibody reservoirs six months later. While Stamets cannot give medical advice and owns Host Defense, you can mirror his personal routine by taking four capsules each of Agarikon and Turkey Tail daily before and during travel, scaling down to onefourth of that at home. Beyond immunity, clinical trials show psilocybin mushrooms are reshaping mental health care. In one clinical study, two high doses of psilocybin kept 90 percent of tobacco-addicted participants smoke-free a year later. However, you must strictly avoid psilocybin if you or your family have a predisposition to psychosis, schizophrenia, or bipolar disorder, and Huberman strongly cautions against use under age 18 due to a lack of data and high youth brain plasticity. Smaller amounts of psilocybin may also sharpen motor speed when paired with the right nutrients. Stamets created the Stamets Stack, combining a psilocybin microdose, Lion's Mane mushroom, and flushing niacin. In citizen-science studies reaching about 25,000 participants, stack users increased their 10-second finger-tapping speed from 43 to 63 taps over 30 days, though Stamets hedges on whether Lion's Mane or niacin drives the boost, increasingly thinking niacin is a force multiplier. Understanding what fungi can and cannot do is just as critical for daily supplements and environmental cleanup. A study of about 73 patients showed cultivated Cordyceps militaris boosts oxygen uptake and performance, whereas Stamets notes wild-cleanup attempts using fungi to clear plastics and dioxins in nature have been a disaster because wild mycelium ignores toxins on nature's buffet table in favor of tastier organic food. Even space dust hints at our deep connection to fungal chemistry. NASA's retrieval of dust from Asteroid Bennu revealed 14 essential amino acids plus tryptophan, which converts in one step into the molecular backbone of both serotonin and psilocybin. Stamets intuits that we live in a tryptamine universe of shared consciousness, though he explicitly hedges that this intuitive leap may take thousands of years to prove. Fungi offer potent tools for viral defense and brain plasticity when used in their whole, natural forms and matched to the right biological jobs. Just because we don't know the mechanisms of action doesn't mean that it's not true.

Episode Overview

  • Applied mycologist Paul Stamets tells Andrew Huberman how medicinal mushrooms, mycelial networks, and psychedelic fungi bolster human immunity, enhance vaccine efficacy, drive neuroplasticity, and support ecological health.
  • The conversation begins with the evolutionary connection between fungi and animals, exploring why underground mycelium acts as the fungal immune system and how fermented substrates regulate human inflammatory cytokines.
  • Stamets presents clinical research on Agarikon and Turkey Tail mycelium for accelerating viral recovery, multiplying vaccine antibody reservoirs, and protecting agricultural honeybees from viral collapse.
  • The discussion transitions to psilocybin clinical trials, exact dosing metrics, psychological safety screening, and large-scale citizen-science data evaluating microdosing stacks for psychomotor performance.
  • The episode concludes by examining functional mushrooms like Cordyceps and Reishi, the dangers of disrupting the human skin mycobiome, the practical realities of environmental mycoremediation, and astrophysical discoveries pointing to a tryptamine-rich universe.

Key Concepts

  • Fungal Evolution, Ecology, and the Mycelial Immune System: Fungi and animals share a common single-celled eukaryotic superkingdom (Opisthokonta) that split 1 to 1.5 billion years ago into Holomycota (fungi, which digest nutrients externally) and Holozoa (animals, which digest nutrients internally in a stomach). While humans as macro-organisms are 90% bacteria, a single cubic inch of rich forest soil can contain 1 to 8 miles of mycelial networks, over 1 million bacterial species, and over 1 billion organisms. Fungi are remarkably resilient: Shaggy Mane mushrooms can break through asphalt and concrete despite being easily crushed by hand, and marine mycology core bores over 1.5 miles down into the ocean floor contain fungi, making oceans potentially Earth's largest fungal reservoir. Out of an estimated 2 to 4 million fungal species (with less than 0.1% tested), human ancestors selected about 200 safe species compatible with our microbiome. Furthermore, 21 or 22 primate species eat mushrooms (often attracted by fly larvae), and a monkey in Bolivia consumes 10% to 15% of its body weight per year in mushrooms; however, when Huberman asks if maternal mushroom consumption drove fetal brain expansion in primate evolution, Stamets hedges that he does not know and wants to be careful what he says. Crucially, mushroom fruitbodies are simply aggregates of mycelium that rot quickly and have poor immune systems, whereas the mycelium is the true immune system of the fungal lifecycle, expressing 10 to 100 times more genes than the fruitbody. Seeing this vast ecosystem cross-talk, an AI expert told Stamets that because AI has hit a "data wall" having discovered 99% of discoverable data in the human experience, researchers are turning toward "natural intelligence."
  • Antiviral Mycelium, Fermented Substrates, and the Entourage Effect: Stamets' antiviral work began in the 1970s when virologist Dr. Frank Piraino (University of Wisconsin Medical School) isolated glycoprotein RC-183 from 20 lbs of Gypsy mushrooms (Rozites caperata / Cortinarius caperatus) supplied by Stamets, proving highly active against herpes virus. After Stamets published a 1-page review in HerbalGram in June 2001, the U.S. BioShield/BioDefense program tested 2,265 assays of his fungal samples for free, placing his natural products in the top 10 out of over 2 million samples for selectivity against weaponizable viruses like orthopox/smallpox and flu. A standout was Agarikon, which grows for over 100 years in old-growth forests, is the only species in its genus and family (compared to 300 species of Reishi), was described by Dioscorides in 65 AD in De Materia Medica as Elixirium ad longam vitam (the elixir of long life), and recently had its first full genome sequencing published by Stamets' team in G3: Genes, Genomes, Genetics. An Agarikon extract in 35% ethanol (containing no beta-glucans, which precipitate out at 25% alcohol) from the 2004 BioShield program sat in a Mason jar for 17 years at room temperature plus 4 years in refrigeration, yet remained massively active against COVID-19 in vitro, healing viral plaque-damaged cells within 5 days. When researchers isolated individual active polyphenols from Agarikon (eburicoic, agaricic, fumaric, and ferulic acids) via bio-guided fractionation, they lost antiviral activity against smallpox when tested individually, proving a whole-complex "entourage effect." Similarly, citing a 2012 breast cancer clinical study and a 2019 Journal of Inflammation Research paper, Stamets explains that growing mycelium on rice ferments the grain into a unique product that stimulates anti-inflammatory cytokines Interleukin-10 (IL-10) and Interleukin-1RA (IL-1RA) to prevent deadly cytokine storms while upregulating immunity. In vitro studies on human peripheral blood mononuclear cells (PBMCs) stimulated with bacterial lipopolysaccharides (LPS) also showed Lion's Mane, Turkey Tail, and Agarikon mycelium dampened inflammation, with Agarikon differentially expressing over 500 genes in human blood cells.
  • Clinical Trials on Viral Infections, Vaccines, and Zoonotic Threats: To fund his research, Stamets created his business Fungi Perfecti and the Host Defense supplement line (which he owns; Huberman states he has "absolutely no financial relationship to Paul's company, Host Defense"). While Stamets has received two NIH grants out of ~10 applications in the past, his COVID-19 and vaccine enhancement trials were privately funded through the Krupp's Institute of Integrative Medicine at UC San Diego and UCLA Medical School. In a double-blind, placebo-controlled trial (BMC Immunology) of 90 participants receiving Pfizer or Moderna mRNA COVID vaccines alongside Agarikon and Turkey Tail mycelium grown on rice (versus a rice placebo) for 4 days, participants experienced a statistically significant reduction in the 10 standard vaccine adverse reaction symptoms (notable because a survey showed 30% of Americans skip the COVID vaccine fearing adverse reactions two days later) and had triple (3x) the COVID antibody reservoirs 6 months later. In a second study of 50 sick COVID-19 patients taking Agarikon and Turkey Tail mycelium without a vaccine intervention (some had prior vaccination), Stamets hedges that when slicing the data three ways, two slices showed statistical significance while the third lacked enough people to understand what happened. The trial showed massive, statistically significant reductions (p-values with three zeros) in headaches, muscle aches, sneezing, and coughing, with 50% symptom resolution occurring 5.1 days sooner than placebo in unvaccinated patients and 1.9 days sooner in previously vaccinated patients (compared to Tamiflu reducing flu duration by ~1 day). Currently, two dairy farms in Washington State are in quarantine for H5N1 bird flu, which has jumped to 90 mammal species (killing seals, sea lions, and marmots) and carries a 40% to 50% human fatality rate; Stamets' team recently received notification of a $2.6 million medical foundation grant with a California university to screen 130 Agarikon strains against viruses like H5N1. In agriculture, Stamets' paper in Nature Scientific Reports (with Washington State University and USDA's Jay Evans) showed feeding honeybees (Apis mellifera) polypore mushroom extracts in sugar water reduced Deformed Wing Virus titers by 14,000 times in 10 days—critical because infected bees only fly for 4 days instead of 7 to 10 days, and one bee pollinates 1,000 flowers a day. However, regulatory hurdles persist: an FDA regulator demanded he characterize all ~200,000 constituents in his bee mushroom extract, and Europe outlawed selling mycelium by classifying it as a "novel food."
  • Psilocybin Clinical Efficacy, Whole Mushroom Dynamics, and Contraindications: Survey data indicates 2.5% of Americans (over 8 million people) used psilocybin last year, and as of the morning of recording, there are 306 psilocybin clinical trials listed on ClinicalTrials.gov (at least 20 using niacin as an active placebo). Observational studies show a statistically significant reduction in crime and partner-to-partner violence after a single psilocybin dose, and a clinical study showed two heroic doses resulted in 90% of tobacco-addicted participants remaining smoke-free 1 year later compared to the nicotine patch. Furthermore, Compass Pathways' trials show a 40% to 45% resolution of treatment-resistant depression and major depressive disorder. In a Johns Hopkins retrospective study led by Roland Griffiths 14 months after a heroic dose, 70% of participants rated it among the top 5 positive experiences of their lives (finding re-remembering it psychologically beneficial), while 30% had a difficult experience, though none of those 30% had lasting adverse effects 14 months later. Comparing formulations, a paper by Dr. Pam Kryskow interviewing 4 individuals who took both synthetic psilocybin and natural psilocybin mushrooms found all 4 preferred natural mushrooms, reporting the synthetic felt "chemical" with a quick liftoff and rapid descent, whereas the mushroom had a long tail aiding reflection. Despite these benefits, Huberman and Stamets emphasize that individuals with a personal or familial predisposition to psychosis, schizophrenia, or bipolar disorder must be screened out and avoid psilocybin. Huberman also hedges strongly against psilocybin use in individuals under age 18 due to a lack of data and high existing brain plasticity in youth, though Stamets notes indigenous traditions and Rick Doblin's FDA discussions explore early intervention around age 16.
  • The "Stamets Stack" and Citizen-Science Microdosing Data: Stamets named the "Stamets Stack" (a psilocybin or psilocybin mushroom microdose, Lion's Mane, and flushing niacin/Vitamin B3) after himself to protect his intellectual attribution. He theorizes that flushing niacin acts as a vasodilator to counteract psilocin's vasoconstriction and drive neurogenic compounds to peripheral nerves. In two observational citizen-science papers published in Nature Scientific Reports using the Quantified Citizen app (reaching ~25,000 participants total, with ~4,500 non-microdosers and a few hundred fewer microdosers in the first paper), microdosers showed significant improvements in mood and reductions in depression and anxiety. Furthermore, on an objective 10-second finger-tapping psychomotor test over 30 days, non-microdosers and psilocybin-only microdosers did not see the jump achieved by "Stamets Stack" users, whose tapping frequency rose from 43 to 63 taps per 10 seconds. However, Stamets hedges on whether Lion's Mane or niacin drives this amplification, noting that in unbundling the stack, he increasingly thinks niacin is a force multiplier.
  • Cordyceps Taxonomy, the Human Mycobiome, and Mycoremediation Realities: In functional mushroom research, wild Cordyceps sinensis fruiting bodies actually contain 5 different co-existing fungal species, causing confusion in scientific literature over which species was studied. Cultivated Cordyceps militaris, however, is well-defined: a study of ~73 patients priming with gram doses for 2 to 3 weeks showed increased adenosine, oxygen uptake, and performance, though it requires weeks of priming rather than working acutely like coffee (whereas Reishi mushrooms can acutely enhance sleep quality). Regarding human fungal ecosystems, Stamets warns that disrupting the vital skin mycobiome with pharmaceutical antifungal antibiotics is dangerous, recounting a friend's father who died a painful death from systemic Candida (thrush) after an allergic reaction to an antifungal medication. When asked about fungi inside the human gut, Stamets hedges that understanding of the internal gut mycobiome is currently much poorer and he cannot speak authoritatively on it. Similarly, after spending millions of dollars researching environmental cleanup (mycoremediation), Stamets candidly separates successes from failures. While oyster mushroom mycelium broke down Bunker C fuel oil (polyaromatic hydrocarbons) from 20,000 ppm to 200 ppm in 16 weeks in Battelle Labs tests and mycelial mats effectively filter E. coli from agricultural runoff, using mycelium to break down dioxins, PCBs, and microplastics in the wild has been a "disaster" and impractical. Although starved mycelium breaks down plastics and dioxins in a Petri dish, in nature it ignores them in favor of more desirable organic food sources on the environmental "buffet table."
  • Asteroid Bennu and the "Tryptamine Universe": Citing NASA's Osiris-REx probe retrieval of dust from Asteroid Bennu (launched in 2016, with findings announced in November 2025), Stamets notes scientists discovered 14 essential amino acids plus tryptophan. Because tryptophan decarboxylates in a single step into tryptamines—which form the molecular backbone of both serotonin and psilocybin—Stamets intuits that we live in a "tryptamine universe" of shared consciousness, though he explicitly hedges that this is an intuitive leap that may take thousands of years to prove.

Quotes

  • At 0:00:11 - "Bird flu has jumped to 90 mammal species, 90. And the fatality rate of H5N1, if it hits humans, is about 40 to 50%. That's going to make COVID look like a minor viral pandemic." - warning about the severity of H5N1 and why his team is screening 130 strains of Agarikon against zoonotic viruses.
  • At 0:04:11 - "The greatest achievement of science this century is the acknowledgment of our ignorance." - framing how much remains undiscovered regarding fungal species and biological cross-talk.
  • At 0:06:06 - "There can be, in a single cubic inch of soil, 1 to 8 miles in rich forest soil of mycelial networks. There can be more than a million species of bacteria, you know, and more than a billion organisms that are co-inhabiting in this latticework of mycelium, which is a membrane." - illustrating the microscopic density of soil ecosystems.
  • At 0:08:23 - "We have come up to a data wall where 99% of discoverable data in the human experience has already been discovered by AI. And there now there's a data deficit. Where do they go next? And he told me that some of the biggest minds in AI, they've identified exactly what I'm talking about: natural intelligence." - explaining why artificial intelligence researchers are looking to biological ecosystems for new data models.
  • At 0:09:22 - "Just because we don't know the mechanisms of action doesn't mean that it's not true." - defending empirical clinical outcomes produced by complex natural products before full molecular characterization is completed.
  • At 0:12:13 - "Mushrooms are made of mycelium. They are aggregates of mycelium. But mushrooms don't have a good immune system. They rot very quickly. You know, they—everyone knows that, you've got to eat mushrooms right away—but the mycelium is the immune system of the mushroom life cycle." - clarifying why underground mycelium expresses 10 to 100 times more genes than fruitbodies.
  • At 0:25:00 - "The danger here is that some of the most deadly poisonous mushrooms in the world are delicious, but it's your last meal." - highlighting the lethal toxicity of certain wild mushroom species.
  • At 0:31:37 - "We found that when you grow the mycelium on rice, separate from the mycelium, separate from the fruitbody, it ferments the rice into a myco-fermented unique product. We published in the Journal of Inflammation Research that it stimulates Interleukin-10 and Interleukin-1RA, as you know, anti-inflammatory cytokines." - refuting claims that rice substrate is mere filler by explaining its anti-inflammatory bioactivity.
  • At 0:34:46 - "It turns out, statistically significant, those people who took Agarikon and Turkey Tail and had the vaccine had triple the antibody reservoirs against COVID than those individuals who just got the vaccine." - sharing 6-month follow-up results from the 90-person UC San Diego and UCLA mRNA vaccine trial.
  • At 0:38:05 - "How long did it—was there a resolution of a reduction of 50% of the symptoms with people who were unvaccinated who took Agarikon and Turkey Tail? 5.1 days sooner than placebo. Those people who were vaccinated and got Agarikon and Turkey Tail? 1.9 days." - detailing symptom recovery speed in the 50-patient active COVID-19 clinical trial.
  • At 0:50:11 - "When we tested those molecules individually, they didn't have the same effect. It was like, wow, we found active constituents—it's called bio-guided fractionation... So bio-guided fractionation, you can bio-fractionate into inactivity." - explaining how isolating individual polyphenols from Agarikon destroyed their antiviral efficacy against smallpox.
  • At 0:59:31 - "My legacy, I want to be: 'Wow, he was on the edge. He was a, you know, an edge runner. He was way out there, but damn it, he was right on some of these things, and millions of lives have been saved as a result.'" - reflecting on his motivation for funding clinical trials through his private business.
  • At 1:08:13 - "I published in Nature science with my colleagues reducing viruses in honeybees up to 14,000 times less viruses in honeybees in 10 days." - summarizing the impact of polypore mushroom extracts on Deformed Wing Virus in Apis mellifera.
  • At 1:09:33 - "She said, 'Okay, we want you to characterize all the constituents inside this natural product.' And I said, 'May I say something?' And she said, 'Yes.' And I said, 'You know there's more than 200,000 constituents in this product. You want us to characterize every single one of them?' And she literally couldn't say anything, like for 45 seconds." - illustrating how pharmaceutical regulatory standards struggle to evaluate complex botanical and fungal extracts.
  • At 1:18:15 - "In the abundance of caution, this is very, very serious. They need to be pre-screened. They need—uh, we need to have adults in the room on this. This is not a party drug. This is serious medicine." - stressing the necessity of psychiatric screening and supervision for psilocybin use.
  • At 1:19:50 - "People need to realize this is an anti-addictive drug. So many people, when they take a high dose of psilocybin, they look at the mushrooms the next day and they say, 'No way, I'm not touching those.' Many people use it one time in their life." - contrasting psilocybin's self-limiting nature with addictive substances.
  • At 1:32:07 - "Psilocybin mushrooms should be available for everybody for free, because the return on investment to society is in the many billions and billions of dollars." - arguing for the societal and economic value of psychedelic mental health interventions.
  • At 1:39:15 - "One-tenth of a gram of Psilocybe cubensis is 1 milligram. 1 gram is 10 milligrams. 5 grams is 50 milligrams. The FDA has approved 25 milligrams, or 2.5 grams of mushrooms, as the standard dose." - providing the 1% conversion scale between dried Psilocybe cubensis weight and pure psilocybin content.
  • At 1:52:29 - "And those people who did the Stamets Stack, in 30 days, the tapping frequency for the stackers went from 43 to 63. That's a psychomotor benefit." - citing objective psychomotor data from his citizen-science microdosing studies in Nature Scientific Reports.
  • At 2:16:01 - "Think of it this way: it's like you have a buffet table, and you're the fungus and you're hungry, and you got all this delicious food in the—on the buffet table, and at the end of it's this toxin, dioxin. What are you going to eat first? Well, you're going to eat the delicious food." - explaining why deploying fungi in nature to degrade plastics and dioxins fails compared to starved Petri dish experiments.

Takeaways

  • Adjust Immune Mycelium Dosing Around Travel: While Stamets notes he cannot make medical recommendations and owns Host Defense (with products visible on the table), he personally takes a prophylactic/therapeutic dose of 4 capsules each of Host Defense Agarikon and Turkey Tail daily for several days prior to and during public travel, scaling back by a 4x difference to a maintenance dose when at home.
  • Use Fermented Rice Mycelium to Modulate Cytokines: Rather than avoiding mushroom supplements grown on grain, look for mycelium cultured on fermented rice when seeking both innate immune upregulation and anti-inflammatory cytokine stimulation (IL-10 and IL-1RA) to help prevent excess inflammatory responses.
  • Preserve the Whole Fungal Complex in Antiviral Extracts: Rely on whole-complex fungal extracts rather than isolated single molecules for immune support, and note that an Agarikon extract in 35% ethanol (which contains no beta-glucans, as they precipitate out at 25% alcohol) retained potent in vitro antiviral activity even after 17 years at room temperature and 4 years in refrigeration.
  • Calculate Psilocybin Doses Using the 1% Psilocybe cubensis Scale: In legal or clinical contexts, equate dried Psilocybe cubensis (~1% psilocybin) to pure psilocybin as follows: a sub-sensorium microdose is 0.1g to 0.3g (1mg to 3mg psilocybin); a medium or "museum" dose is ~0.5g (5mg); a liftoff dose is 1g (10mg psilocybin, converting to 5mg active psilocin in the body); and a standard FDA clinical trial or heroic dose is 2.5g to 5g (25mg to 50mg, standardized by the FDA at 25mg).
  • Screen Out Psychotic and Bipolar Predispositions Before Using Psychedelics: Strictly screen out anyone with a personal or familial predisposition to psychosis, schizophrenia, or bipolar disorder before administering psilocybin, and heed Huberman's strong caution against use in individuals under age 18 due to lacking data and high baseline youth brain plasticity.
  • Favour Whole Psilocybin Mushrooms Over Synthetic Isolates for Reflection: Where clinically or legally applicable, consider that patients comparing synthetic psilocybin to natural mushrooms preferred the whole mushroom for its gentle ascent and long reflective tail, whereas the synthetic version produced a rapid, "chemical"-feeling liftoff and drop.
  • Combine Microdosing with Lion's Mane and Flushing Niacin for Psychomotor Gains: In legal jurisdictions, pairing a psilocybin microdose with Lion's Mane and flushing niacin (Vitamin B3, used as a vasodilator) over 30 days can improve psychomotor speed (increasing 10-second finger tapping from 43 to 63 taps), though Stamets hedges that niacin may be the primary force multiplier.
  • Prime with Cordyceps militaris for Weeks Rather Than Expecting Acute Energy: To increase adenosine, oxygen uptake, and physical performance, supplement with gram doses of cultivated Cordyceps militaris consistently for 2 to 3 weeks rather than treating it as an acute stimulant like coffee.
  • Take Reishi Acutely for Sleep Support: Unlike Cordyceps, which requires multi-week priming, use Reishi mushrooms acutely when targeting immediate improvements in sleep quality.
  • Protect the Skin Mycobiome from Unnecessary Antifungal Antibiotics: Avoid disrupting the skin's fungal homeostasis with pharmaceutical antifungal antibiotics unless medically critical, as wiping out beneficial skin fungi can trigger fatal systemic Candida (thrush) infections or severe allergic reactions.
  • Target Hydrocarbons and E. coli for Practical Mycoremediation: Deploy oyster mushroom mycelium to remediate petroleum/fuel oil spills (polyaromatic hydrocarbons) and mycelial mats to filter E. coli from agricultural runoff, rather than attempting to use fungi in the wild to clear microplastics, PCBs, or dioxins.
  • Build Cardiovascular Longevity with High-Repetition Push-Up Sets: Incorporate single-set push-up training into your weekly routine; Stamets (who is 71, takes no prescription drugs, and did 95 push-ups that morning) points to Harvard research showing men capable of doing 40 push-ups in a single set three times a week have a 97% lower risk of cardiac arrest.

(Note on episode sponsors mentioned by Andrew Huberman: Eight Sleep smart mattress covers; Our Place PFAS-free cookware, with Huberman noting he uses their Titanium Always Pan Pro; AG1, with Huberman noting he takes ingredients in AG1 Pro; Joovv red light therapy devices, with Huberman using their panels and handhelds; and Function biomarker analysis, which Huberman used to test his blood lipids.)